Eyenovia Valuation
| EYEN Stock | USD 0.11 0.02 19.05% |
Eyenovia seems to be undervalued based on Macroaxis valuation methodology. Our model computes the value of Eyenovia from reviewing the firm fundamentals such as Shares Owned By Insiders of 9.99 %, operating margin of (516.61) %, and Shares Outstanding of 86.44 M as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Eyenovia's valuation include:
Price Book 2.1475 | Enterprise Value 13.8 M | Enterprise Value Ebitda (5.41) | Price Sales 254.3291 | Enterprise Value Revenue 433.8631 |
Undervalued
Today
Please note that Eyenovia's price fluctuation is dangerous at this time. Calculation of the real value of Eyenovia is based on 3 months time horizon. Increasing Eyenovia's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Eyenovia is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Eyenovia Stock. However, Eyenovia's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.11 | Real 3.0 | Target 11.67 | Hype 0.13 |
The intrinsic value of Eyenovia's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Eyenovia's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Eyenovia helps investors to forecast how Eyenovia stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Eyenovia more accurately as focusing exclusively on Eyenovia's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Eyenovia's intrinsic value based on its ongoing forecasts of Eyenovia's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Eyenovia's closest peers.
Eyenovia Cash |
|
Eyenovia Valuation Trend
Knowing Eyenovia's actual value is paramount for traders when making sound investment determinations. Using both Eyenovia's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Eyenovia Total Value Analysis
Eyenovia is currently forecasted to have valuation of 13.81 M with market capitalization of 7.99 M, debt of 16.08 M, and cash on hands of 21.51 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Eyenovia fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
13.81 M | 7.99 M | 16.08 M | 21.51 M |
Eyenovia Investor Information
About 14.0% of the company shares are held by institutions such as insurance companies. The book value of Eyenovia was currently reported as 0.2. The company recorded a loss per share of 0.69. Eyenovia had not issued any dividends in recent years. Based on the key measurements obtained from Eyenovia's financial statements, Eyenovia is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Eyenovia Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Eyenovia has an asset utilization ratio of 0.0132 percent. This suggests that the Company is making $1.32E-4 for each dollar of assets. An increasing asset utilization means that Eyenovia is more efficient with each dollar of assets it utilizes for everyday operations.Eyenovia Ownership Allocation
Eyenovia holds a total of 86.44 Million outstanding shares. Eyenovia shows 9.99 percent of its outstanding shares held by insiders and 13.73 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Eyenovia Profitability Analysis
The company reported the previous year's revenue of 3.79 K. Net Loss for the year was (27.26 M) with profit before overhead, payroll, taxes, and interest of 12.4 M.About Eyenovia Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Eyenovia. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Eyenovia based exclusively on its fundamental and basic technical indicators. By analyzing Eyenovia's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Eyenovia's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Eyenovia. We calculate exposure to Eyenovia's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Eyenovia's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -783.2 K | -744 K | |
| Pretax Profit Margin | -8.3 K | -7.9 K | |
| Operating Profit Margin | -7.7 K | -7.3 K | |
| Net Loss | -8.3 K | -7.9 K | |
| Gross Profit Margin | 0.80 | 0.59 |
Eyenovia Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 41 M |
Eyenovia Current Valuation Indicators
Eyenovia's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Eyenovia's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Eyenovia, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Eyenovia's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Eyenovia's worth.When determining whether Eyenovia offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eyenovia's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eyenovia Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eyenovia Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eyenovia. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Eyenovia Stock, please use our How to Invest in Eyenovia guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eyenovia. If investors know Eyenovia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eyenovia listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.69) | Revenue Per Share 0.001 | Quarterly Revenue Growth 4 | Return On Assets (0.93) | Return On Equity (9.15) |
The market value of Eyenovia is measured differently than its book value, which is the value of Eyenovia that is recorded on the company's balance sheet. Investors also form their own opinion of Eyenovia's value that differs from its market value or its book value, called intrinsic value, which is Eyenovia's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eyenovia's market value can be influenced by many factors that don't directly affect Eyenovia's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eyenovia's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eyenovia is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eyenovia's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.